Simple sugary drink before surgery may get bowels moving faster

NCT ID NCT07684755

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This trial tests whether giving patients a carbohydrate-rich drink before ileostomy reversal surgery helps their bowels start working again sooner. After ileostomy reversal, up to 30% of people experience a temporary slowdown in bowel function, causing nausea, bloating, and longer hospital stays. The study will compare those who receive the carbohydrate drink to those who get a placebo, measuring when they pass gas, have bowel sounds, and can eat solid food.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Carbohydrate drink
What this could lead to
If it works, this simple pre-surgery drink could help people recover bowel function faster after ileostomy reversal, shortening hospital stays.
What could go wrong
This is a small, early-stage trial, so results may not apply to everyone. The drink may not speed recovery or could cause discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

66 people

The number who actually took part.

Started

Nov 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age above 18 years * ASA class 2 and below Exclusion Criteria: * · Evidence of chronic/active intestinal disease * Post-operative complication/morbidity besides postoperative ileus * Failure of conservative management at more than 72 hours

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ileostomy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Indus Hospital and Health Network

    Karachi, Sindh, 45500, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.